Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06PVF
|
|||
| Former ID |
DNC002697
|
|||
| Drug Name |
(Hydroxyethyloxy)Tri(Ethyloxy)Octane
|
|||
| Synonyms |
19327-39-0; 3,6,9,12-tetraoxaicosan-1-ol; 3,6,9,12-Tetraoxaeicosan-1-ol; TETRAETHYLENE GLYCOL MONOOCTYL ETHER; (Hydroxyethyloxy)tri(Ethyloxy)octane; Tetraethylene glycol monoctyl ether; C8E4; FEOZZFHAVXYAMB-UHFFFAOYSA-N; C8E; Octyltetraglycol; Octyltetraethyleneoxide; AC1L1KAZ; AC1Q58VY; SCHEMBL185557; Octyl tetraethylene glycol ether; DTXSID3066479; CHEBI:41323; CTK0H5811; Tetraethylene glycol, octyl ether; tetraethyleneglycol monooctyl ether; MolPort-003-939-472; MFCD00043033; ZINC14881140; AKOS027320403; DB04233; KS-00000Y06
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H34O5
|
|||
| Canonical SMILES |
CCCCCCCCOCCOCCOCCOCCO
|
|||
| InChI |
1S/C16H34O5/c1-2-3-4-5-6-7-9-18-11-13-20-15-16-21-14-12-19-10-8-17/h17H,2-16H2,1H3
|
|||
| InChIKey |
FEOZZFHAVXYAMB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 19327-39-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
821010, 821382, 821384, 821386, 821388, 821390, 821392, 821394, 827855, 827856, 827857, 827859, 828276, 828288, 828290, 828302, 829227, 830408, 830952, 830968, 833392, 855432, 3133717, 5641341, 7886452, 7889620, 8153331, 10318322, 11532735, 11538618, 14751987, 17436393, 24848032, 24900138, 26703320, 26710124, 26717462, 26717503, 26717953, 26718698, 26718707, 26719186, 26719293, 26719393, 26719512, 26736883, 26744276, 29224466, 46506525, 49742992
|
|||
| ChEBI ID |
CHEBI:41323
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Pancreatic triacylglycerol lipase (PNLIP) | Target Info | Inhibitor | [1] |
| Rhodopsin (RHO) | Target Info | Inhibitor | [1] | |
| BioCyc | Triacylglycerol degradation | |||
| Retinol biosynthesis | ||||
| KEGG Pathway | Glycerolipid metabolism | |||
| Metabolic pathways | ||||
| Pancreatic secretion | ||||
| Fat digestion and absorption | ||||
| Vitamin digestion and absorption | ||||
| Phototransduction | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction | |||
| Pathway Interaction Database | Visual signal transduction: Rods | |||
| Reactome | Retinoid metabolism and transport | |||
| The canonical retinoid cycle in rods (twilight vision) | ||||
| Inactivation, recovery and regulation of the phototransduction cascade | ||||
| G alpha (i) signalling events | ||||
| WikiPathways | Visual phototransduction | |||
| Lipid digestion, mobilization, and transport | ||||
| GPCRs, Class A Rhodopsin-like | ||||
| Regulation of Microtubule Cytoskeleton | ||||
| Integrated Breast Cancer Pathway | ||||
| Integrin-mediated Cell Adhesion | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.